(CRM) Salesforce.com - Overview
Sector: Technology | Industry: Software - Application | Exchange: NYSE (USA) | Market Cap: 137.089m USD | Total Return: -39.9% in 12m
Industry Rotation: +23.5
Avg Turnover: 2.10B
EPS Trend: 84.1%
Qual. Beats: 3
Rev. Trend: 98.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Salesforce, Inc. (CRM) is a global provider of cloud-based customer relationship management (CRM) software, operating primarily within the Application Software sub-industry. The company utilizes a Software-as-a-Service (SaaS) business model, which generates predictable recurring revenue through multi-year subscription contracts. Its core offerings include the Agentforce AI platform, Data 360 engine, and Slack, designed to integrate autonomous agents with human workflows across sales, service, and marketing functions.
The company serves diverse sectors including financial services, healthcare, and manufacturing, facilitating data unification and real-time collaboration. As a pioneer in cloud computing, Salesforce maintains a dominant market share in the CRM space, benefiting from high switching costs and a vast ecosystem of third-party integrations. For a deeper look at these fundamentals, ValueRay provides additional historical context and comparative data.
Recent strategic shifts focus on the agentic enterprise, where AI agents automate routine tasks while leveraging the companys proprietary data management tools like Informatica. This infrastructure allows organizations to scale operations across hybrid and multi-cloud environments while maintaining data governance and security protocols.
- Agentforce adoption drives high-margin subscription growth through autonomous AI agent deployment
- Enterprise software spending cycles influence multi-year contract renewals and billings
- Data Cloud integration fuels cross-selling opportunities within the existing customer base
- Operating margin expansion remains dependent on sustained cost discipline and headcount management
- Slack monetization and integration performance impact long-term enterprise collaboration revenue targets
| Net Income: 7.46b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.74 > 1.0 |
| NWC/Revenue: -21.42% < 20% (prev 4.61%; Δ -26.03% < -1%) |
| CFO/TA 0.13 > 3% & CFO 15.00b > Net Income 7.46b |
| Net Debt (9.85b) to EBITDA (12.72b): 0.77 < 3 |
| Current Ratio: 0.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (940.0m) vs 12m ago -3.49% < -2% |
| Gross Margin: 77.68% > 18% (prev 0.77%; Δ 7.69k% > 0.5%) |
| Asset Turnover: 38.59% > 50% (prev 36.82%; Δ 1.77% > 0%) |
| Interest Coverage Ratio: 45.02 > 6 (EBITDA TTM 12.72b / Interest Expense TTM 202.0m) |
| A: -0.08 (Total Current Assets 28.22b - Total Current Liabilities 37.12b) / Total Assets 112.31b |
| B: 0.20 (Retained Earnings 22.22b / Total Assets 112.31b) |
| C: 0.08 (EBIT TTM 9.09b / Avg Total Assets 107.62b) |
| D: 0.42 (Book Value of Equity 22.54b / Total Liabilities 53.16b) |
| Altman-Z'' Score: 1.14 = BB |
| DSRI: 1.10 (Receivables 14.34b/11.95b, Revenue 41.52b/37.90b) |
| GMI: 0.99 (GM 77.68% / 77.19%) |
| AQI: 1.07 (AQ_t 0.70 / AQ_t-1 0.66) |
| SGI: 1.10 (Revenue 41.52b / 37.90b) |
| TATA: -0.07 (NI 7.46b - CFO 15.00b) / TA 112.31b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
Over the past week, the price has changed by -4.57%, over one month by -2.30%, over three months by -5.61% and over the past year by -39.88%.
- StrongBuy: 28
- Buy: 13
- Hold: 12
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 268.3 | 54.6% |
P/E Forward = 13.8122
P/S = 3.3014
P/B = 2.5149
P/EG = 0.9865
Revenue TTM = 41.52b USD
EBIT TTM = 9.09b USD
EBITDA TTM = 12.72b USD
Long Term Debt = 10.44b USD (from longTermDebt, last quarter)
Short Term Debt = 4.55b USD (from shortTermDebt, last quarter)
Debt = 17.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.85b USD (from netDebt column, last quarter)
Enterprise Value = 146.94b USD (137.09b + Debt 17.18b - CCE 7.33b)
Interest Coverage Ratio = 45.02 (Ebit TTM 9.09b / Interest Expense TTM 202.0m)
EV/FCF = 10.20x (Enterprise Value 146.94b / FCF TTM 14.40b)
FCF Yield = 9.80% (FCF TTM 14.40b / Enterprise Value 146.94b)
FCF Margin = 34.68% (FCF TTM 14.40b / Revenue TTM 41.52b)
Net Margin = 17.96% (Net Income TTM 7.46b / Revenue TTM 41.52b)
Gross Margin = 77.68% ((Revenue TTM 41.52b - Cost of Revenue TTM 9.27b) / Revenue TTM)
Gross Margin QoQ = 77.61% (prev 78.02%)
Tobins Q-Ratio = 1.31 (Enterprise Value 146.94b / Total Assets 112.31b)
Interest Expense / Debt = 0.39% (Interest Expense 67.0m / Debt 17.18b)
Taxrate = 26.07% (685.0m / 2.63b)
NOPAT = 6.72b (EBIT 9.09b * (1 - 26.07%))
Current Ratio = 0.76 (Total Current Assets 28.22b / Total Current Liabilities 37.12b)
Debt / Equity = 0.29 (Debt 17.18b / totalStockholderEquity, last quarter 59.14b)
Debt / EBITDA = 0.77 (Net Debt 9.85b / EBITDA 12.72b)
Debt / FCF = 0.68 (Net Debt 9.85b / FCF TTM 14.40b)
Total Stockholder Equity = 60.29b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.93% (Net Income 7.46b / Total Assets 112.31b)
RoE = 12.37% (Net Income TTM 7.46b / Total Stockholder Equity 60.29b)
RoCE = 12.86% (EBIT 9.09b / Capital Employed (Equity 60.29b + L.T.Debt 10.44b))
RoIC = 9.57% (NOPAT 6.72b / Invested Capital 70.23b)
WACC = 8.35% (E(137.09b)/V(154.27b) * Re(9.36%) + D(17.18b)/V(154.27b) * Rd(0.39%) * (1-Tc(0.26)))
Discount Rate = 9.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -76.41 | Cagr: -1.88%
[DCF] Terminal Value 80.45% ; FCFF base≈13.61b ; Y1≈16.80b ; Y5≈28.66b
[DCF] Fair Price = 549.3 (EV 459.21b - Net Debt 9.85b = Equity 449.36b / Shares 818.1m; r=8.35% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 84.06 | EPS CAGR: 43.63% | SUE: 4.00 | # QB: 3
Revenue Correlation: 98.37 | Revenue CAGR: 11.64% | SUE: 0.56 | # QB: 0
EPS current Quarter (2026-07-31): EPS=3.24 | Chg30d=-0.10% | Revisions=+0% | Analysts=43
EPS current Year (2027-01-31): EPS=13.20 | Chg30d=-0.02% | Revisions=-11% | GrowthEPS=+5.5% | GrowthRev=+11.1%
EPS next Year (2028-01-31): EPS=14.94 | Chg30d=-0.06% | Revisions=+0% | GrowthEPS=+13.2% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: -11%